Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05763628 · ClinicalTrials.gov registry record · NA
Performance Evaluation of Different Daily Disposable Multifocal Contact Lenses
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT05763628 is a NA study that has completed, run by CooperVision. The registered enrollment target is 59 participants.
The verdict
NCT05763628, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
The objective of the study was to compare the lens performance of two daily disposable multifocal contact lenses.
Interventions
- DEVICE Control Lens (stenfilcon A)
- DEVICE Test Lens (senofilcon A)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2022-12-10 |
| Est. Completion | 2023-06-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05763628
The ClinicalTrials.gov registry entry for NCT05763628 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control Lens (stenfilcon A) is the first listed.
NCT05763628 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05763628 about?
NCT05763628 is a clinical study titled "Performance Evaluation of Different Daily Disposable Multifocal Contact Lenses". The objective of the study was to compare the lens performance of two daily disposable multifocal contact lenses.
What is the current status of trial NCT05763628?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2022-12-10. Estimated completion is 2023-06-15.
What interventions are being tested in trial NCT05763628?
The interventions under investigation include: Control Lens (stenfilcon A) (DEVICE), Test Lens (senofilcon A) (DEVICE).
Who is sponsoring clinical trial NCT05763628?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.